Wealthfront Advisers’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
KA
Wealthfront Advisers's TDOC Position: Q3 2022 in Review
Wealthfront Advisers sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 81,183 shares — an estimated $2.7M sold.
Wealthfront Advisers first reported a position in TDOC in Q2 2021 and held it in 3 quarters. The position peaked at $2.7M in Q2 2022. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.
- Wealthfront Advisers reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
- Wealthfront Advisers sold 81,183 Teladoc Health shares in Q3 2022, an estimated $2.7M.
- Wealthfront Advisers first reported a position in Teladoc Health in Q2 2021 and held it in 3 quarters.
- Wealthfront Advisers's Teladoc Health position peaked at $2.7M in Q2 2022.
- 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.
Based on Wealthfront Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.